Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
Modulation of equine platelet function by diethylcarbamazine (DEC).
The American journal of pathology    October 1, 1983   Volume 113, Issue 1 1-7 
Kowalski KA, McConnell LA, Sadoff DA, Leid RW.Equine platelets, when treated with the anthelmintic drug diethylcarbamazine (DEC), gave a dose-dependent release of radiolabeled serotonin without concomitant aggregation. At levels of the drug that gave only minimal release of radiolabel, marked dose-dependent inhibition of platelet aggregation to three of four platelet agonists tested--adenosine diphosphate (ADP), collagen, and arachidonic acid--was observed. With ADP, inhibition was observed to be reversed by removal of DEC prior to agonist challenge. However, with collagen, inhibition was only partially reduced by prior removal of DEC; wh...
Pharmacokinetics of chloramphenicol in the neonatal horse.
Journal of veterinary pharmacology and therapeutics    September 1, 1983   Volume 6, Issue 3 219-227 doi: 10.1111/j.1365-2885.1983.tb00467.x
Brumbaugh GW, Martens RJ, Knight HD, Martin MT.Chloramphenicol sodium succinate was administered as an intravenous bolus (50 mg/kg) to eight foals which weighed 49-57 kg (mean +/- 1 standard deviation = 53.19 +/- 2.66) each, and were 1-9 days (4.5 +/- 2.56) of age. The drug was rapidly distributed and followed first-order elimination. Mean pharmacokinetic values were: zero-time serum concentration (C0) = 36.14 microgram/ml (+/- 14.80); apparent specific volume of distribution (Vd) = 1.614 1/kg (+/- 0.669); and elimination rate constant (K) = 0.7295 h-1 (+/- 0.3066) which corresponds to a biological half-life (t1/2) = 0.95 h. These values d...
Gentamicin pharmacokinetics in horses given small doses of Escherichia coli endotoxin.
American journal of veterinary research    September 1, 1983   Volume 44, Issue 9 1746-1749 
Wilson RC, Moore JN, Eakle N.The pharmacokinetics of gentamicin (3 mg/kg of body weight) were evaluated in 6 healthy horses and in 6 horses after they were given Escherichia coli endotoxin (0.113 microgram/kg). In the horses given endotoxin, there were a maximum temperature increase of 1.97 +/- 0.44 degrees (C) and a fever index (between the 2 groups) of 8.754 units. Other mild signs of endotoxemia also occurred. Statistically significant changes were not observed in the rate constants for distribution (alpha) or elimination (beta) or in body clearance (ClB) of gentamicin in the 2 groups of horses. In the horses given end...
A new analgesic drug combination in the horse.
American journal of veterinary research    September 1, 1983   Volume 44, Issue 9 1667-1669 
Robertson JT, Muir WW.A xylazine and butorphanol drug combination produced minimal and transient hemodynamic effects and no significant respiratory depression when administered to 6 healthy horses. Combining xylazine and butorphanol produced a synergistic analgesic effect and provided good chemical restraint for a standing surgical procedure.
Adverse reactions to drugs.
In practice    September 1, 1983   Volume 5, Issue 5 174-180 doi: 10.1136/inpract.5.5.174
Keen P, Livingston A.No abstract available
A pharmacokinetic study of digoxin in the horse.
Journal of veterinary pharmacology and therapeutics    September 1, 1983   Volume 6, Issue 3 163-172 doi: 10.1111/j.1365-2885.1983.tb00460.x
Brumbaugh GW, Thomas WP, Enos LR, Kaneko JJ.Digoxin was administered orally and intravenously to seven healthy adult mares and geldings in two separate trials. At a dose of 44 microgram digoxin/kg body weight, the oral study was characterized by an absorption phase with a mean (+/- 1 standard deviation) peak serum digoxin concentration of 2.21 ng/ml (+/- 0.45) at a mean of 2.29 h (+/- 1.52) after administration. A second rise in serum digoxin concentration started about 6-8 h after administration and extended to about 20 h after administration. The mean bioavailability (F) was 23.38% (+/- 5.96). At a dose of 22 microgram digoxin/kg body...
Ivermectin: a potent new antiparasitic agent.
Science (New York, N.Y.)    August 26, 1983   Volume 221, Issue 4613 823-828 doi: 10.1126/science.6308762
Campbell WC, Fisher MH, Stapley EO, Albers-Schönberg G, Jacob TA.Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis. It is active at extremely low dosage against a wide variety of nematode and arthropod parasites, apparently by virtue of its action on the mediation of neurotransmission by gamma-aminobutyric acid. It is now in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs. Since studies with the drug in man are in a preliminary stage, it is not yet kn...
Clinical efficacy of a revised dosage schedule of phenylbutazone in horses.
The Veterinary record    August 20, 1983   Volume 113, Issue 8 183-184 doi: 10.1136/vr.113.8.183
Taylor JB, Verrall JH, Chandler N, Jones RD, Parker J.No abstract available
Relative activities of acyclovir and BW759 against Aujeszky’s disease and equine rhinopneumonitis viruses.
Antimicrobial agents and chemotherapy    August 1, 1983   Volume 24, Issue 2 221-226 doi: 10.1128/AAC.24.2.221
Rollinson EA, White G.Compound BW759 (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine) was shown to be about 230 times more active than acyclovir (9-[2-hydroxyethoxymethyl]guanine) (ACV) against Equid herpesvirus type 1 infection in Syrian hamsters and was more effective against Aujeszky's disease in mice. The therapeutic superiority of BW759 over ACV was greater than expected from quantitative inhibitory results in tissue culture with these viruses. When administered to hamsters at dose rates sufficient to prevent any Equid herpesvirus type 1-induced mortality (100 mg of ACV per kg per day; 3 mg of BW759 per kg...
Effect of isometamidium on infections by Trypanosoma vivax and T. evansi in experimentally-infected animals.
Veterinary parasitology    August 1, 1983   Volume 13, Issue 1 35-43 doi: 10.1016/0304-4017(83)90018-3
Toro M, León E, López R, Pallota F, Garcia JA, Ruíz A.Assays dealing with the therapeutic and prophylactic activity of isometamidium on experimental infections by Trypanosoma vivax and T. evansi were carried out. The drug was found to be highly effective against T. vivax infection in sheep and cattle in which periods of protection ranging from 118 to 195 days were achieved. No complete effects against infection by T. evansi were observed. The drug was well tolerated in sheep and cattle while side-effects were noted in treated mares. It was concluded that isometamidium could be used to prevent damage and economical losses caused by T. vivax in Ven...
The effect of altrenogest, an oral progestin, on hematologic and biochemical parameters in mares.
Veterinary and human toxicology    August 1, 1983   Volume 25, Issue 4 250-252 
Shideler RK, Voss JL, Aufderheide WM, Hessemann CP, Squires EL.Twenty mares were assigned to 1 of 4 groups: no altrenogest; altrenogest at 0.044 mg/kg BW; altrenogest at 0.132 mg/kg BW; or altrenogest at 0.220 mg/kg BW. Treatment was administered daily for 86 days. No signs of illness attributable to feeding altrenogest were observed during the trial. Treatment had no effect (P greater than .05) on the following parameters: WBC, differential WBC, platelet number, creatinine, LDH, CPK, total bilirubin, cholesterol, globulin, BSP, and erythrocyte sedimentation rate. When comparing values over time with pretreatment means or among treatment groups, there wer...
Studies on isoxsuprine hydrochloride for the treatment of navicular disease.
Equine veterinary journal    July 1, 1983   Volume 15, Issue 3 238-243 doi: 10.1111/j.2042-3306.1983.tb01778.x
Rose RJ, Allen JR, Hodgson DR, Kohnke JR.A peripheral vasodilating agent, isoxsuprine hydrochloride, administered as an oral paste, was evaluated to determine its efficacy for the treatment of navicular disease. In a clinical trial, 13 horses with navicular disease were treated at a dose rate of 0.6 mg/kg body weight (bwt) twice daily for periods of six to 14 weeks. Twelve of the horses became completely sound while being treated, although two required a 50 per cent increase in dose. Nine of the horses have remained sound two to 10 months after ceasing therapy. In a controlled randomised double blind clinical trial, 16 horses with na...
Cardiovascular and neuromuscular effects of pancuronium bromide in the pony.
American journal of veterinary research    July 1, 1983   Volume 44, Issue 7 1349-1353 
Manley SV, Steffey EP, Howitt GA, Woliner M.No abstract available
Experimental studies of drug-induced impaction colic in the horse.
Equine veterinary journal    July 1, 1983   Volume 15, Issue 3 222-228 doi: 10.1111/j.2042-3306.1983.tb01772.x
Roberts MC, Seawright AA.Colic was induced in horses and ponies following topical or intravenous (iv) administration of amitraz, a formamidine acaricide. The condition was characterised by rapid cessation of intestinal sounds, stasis, extensive impaction and tympany throughout the large colon. Three animals that were necropsied had a faecalith obstructing the proximal small colon aboral to marked colonic impaction. A reproducible and reversible impaction colic syndrome could be induced by an iv injection of 1 mg amitraz/kg body weight in solvent. There were immediate central nervous system and intestinal signs. Large ...
Bioavailability of ‘bute’.
The Veterinary record    June 25, 1983   Volume 112, Issue 26 595 doi: 10.1136/vr.112.26.595
No abstract available
Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses.
The Veterinary record    June 25, 1983   Volume 112, Issue 26 599-602 doi: 10.1136/vr.112.26.599
Taylor JB, Walland A, Lees P, Gerring EL, Maitho TE, Millar JD.Five pairs of matched horses were used to study the biochemical and haematological effects of a revised dosage schedule of phenylbutazone. One group of five horses received a phenylbutazone paste formulation daily for 12 days and a second group of five animals received a placebo preparation for a similar time. Some statistically significant differences were recorded from pretreatment levels in both groups of horses. These changes represented instability in baseline levels and could not be ascribed to phenylbutazone administration.
Studies on a new paste preparation of phenylbutazone.
The Veterinary record    June 25, 1983   Volume 112, Issue 26 602-607 doi: 10.1136/vr.112.26.602
Snow DH, Douglas TA.The absorption characteristics of a new paste preparation of phenylbutazone were studied in ponies and thoroughbreds. The results suggested that at a similar dose rate of 5 mg/kg greater bioavailability results from the paste than from a powder preparation. Delivery of an accurate dosage of the paste was not possible using the multidose applicator. Repeated administration of the paste preparation (5 mg/kg twice daily) indicated that it is more toxic to both ponies and thoroughbreds than a powder preparation. In addition to the toxic manifestations previously reported, a neutropenia developed d...
Influence of acepromazine maleate on the equine haematocrit.
Journal of veterinary pharmacology and therapeutics    June 1, 1983   Volume 6, Issue 2 121-126 doi: 10.1111/j.1365-2885.1983.tb00388.x
Parry BW, Anderson GA.The effect of acepromazine maleate (ACP) on the equine venous haematocrit and total plasma protein concentration was studied in six clinically normal horses. Total plasma protein concentration was not appreciably influenced by ACP. However, the haematocrit decreased with the duration, but not the degree, of the decrease being dose-related. Mean haematocrit values returned to control levels by 12 h after 0.05 mg ACP/kg body weight and 21 h after 0.15 mg ACP/kg body weight.
Pharmacokinetics of phenytoin (diphenylhydantoin) in horses.
Journal of veterinary pharmacology and therapeutics    June 1, 1983   Volume 6, Issue 2 133-140 doi: 10.1111/j.1365-2885.1983.tb00390.x
Kowalczyk DF, Beech J.The pharmacokinetics of the anti-convulsant phenytoin were investigated in clinically healthy horses after oral (p.o.) and intravenous (i.v.) administration. A single dose of phenytoin (8.8 mg/kg body weight) was given i.v. as a bolus to nine horses and one horse received 13.2 mg/kg. A two-compartment open model was used to describe the disposition of phenytoin. Four of the horses that received an i.v. dose (three at 8.8 mg/kg and one at 13.2 mg/kg) were then given the same dose 3 days later by the oral route. Phenytoin achieved a peak concentration in serum within 1-4 h after p.o. administrat...
Evaluation of mebendazole used concurrently with piperazine monohydrochloride in horses.
Journal of the American Veterinary Medical Association    May 15, 1983   Volume 182, Issue 10 1102-1104 
DiPietro JA, Paul A, Todd KS.Forty horses from a herd known to have benzimidazole-resistant small strongyles were treated with mebendazole (8.8 mg/kg) or combinations of mebendazole and piperazine monohydrochloride (25, 40, or 55 mg of piperazine base/kg). Pretreatment and 7-day posttreatment fecal examinations were done. Fecal cultures and strongyle egg per gram (epg) counts, and in vitro testing for benzimidazole resistance were performed. Results of fecal examinations prior to treatment were similar in all horses, and results of testing were positive for benzimidazole resistance. Horses treated with mebendazole and pip...
Cumulative dose responses to gallamine, pancuronium, and neostigmine in halothane-anesthetized horses: neuromuscular and cardiovascular effects.
American journal of veterinary research    May 1, 1983   Volume 44, Issue 5 786-792 
Klein L, Hopkins J, Beck E, Burton B.No abstract available
Effect of spasmolytic analgesic drugs on the motility patterns of the equine small intestine.
Research in veterinary science    May 1, 1983   Volume 34, Issue 3 334-339 
Davies JV, Gerring EL.The effect of acepromazine, Buscopan (Crown Chemicals), pethidine and methadone was evaluated in ponies prepared with Thiry-Vella (T-V) loops. Motility was assessed by electrophysiological means (bipolar electrodes and strain gauge transducers) and by the passage through the T-V loop of a fluid test meal. Results were obtained from 26 experiments in three ponies and compared with six control experiments, in which saline had been administered to the same ponies. Each pony acted as its own control in each experiment and pre and post treatment values for slow wave frequency, spiking activity, del...
The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
Drug metabolism and disposition: the biological fate of chemicals    May 1, 1983   Volume 11, Issue 3 226-231 
Chay S, Woods WE, Rowse K, Nugent TE, Blake JW, Tobin T.Studies were undertaken to determine blood levels of furosemide in horses after 0.5- and 1.0-mg/kg doses administered iv. Analyses indicated that the pharmacokinetic parameters were dose independent and best described by a three-compartment open model. The alpha-, beta-, and gamma-phase half-lives of 5.6, 22.3, and 158.5 min, respectively, were observed after the 0.5-mg/kg dose. Similarly, the respective half-lives after the 1.0-mg/kg dose were 5.8, 24.1, and 177.2 min. After a 0.5-mg/kg dose of furosemide, population frequency distributions were evaluated at 1 hr and 4 hr post-drug administra...
Pharmacokinetics and protein binding of morphine in horses.
American journal of veterinary research    May 1, 1983   Volume 44, Issue 5 870-874 
Combie JD, Nugent TE, Tobin T.Morphine could be detected in horses dosed with 0.1 mg of drug/kg of body weight for up to 48 hours in blood and 144 hours in urine. This dose of morphine elicited no observable effects and is a suggested analgesic dose. Computer analysis revealed that a 3-compartment open system was the best fitting model with a serum half life (t1/2(beta)) of 87.9 minutes and a urine t1/2(beta) of 101.1 minutes. Binding to equine serum proteins was linear over a drug concentration range of 3.88 X 10(-5)M to 3.50 X 10(-8)M and averaged 31.6%. In RBC-partitioning experiments, 78.1% of the drug was found in the...
The metabolism of fenclofenac in the horse.
Xenobiotica; the fate of foreign compounds in biological systems    April 1, 1983   Volume 13, Issue 4 233-240 doi: 10.3109/00498258309052259
Marsh MV, Caldwell J, Sloan TP, Smith RL, Horner M, Moss MS.14C-Fenclofenac (2-(2'-4'-dichlorophenoxy)-phenylacetic acid) was administered orally to horses, and urinary metabolites investigated by chromatography. Fenclofenac was rapidly absorbed and eliminated, with a plasma half-life (t1/2) of 2.3 h, with 83.2 and 85.8% of the dose being recovered in the urine in 0-24 h. The major urinary metabolite was the ester glucuronide (58.8, 70.0% dose), and evidence is presented that this metabolite undergoes a structural rearrangement to give beta-glucuronidase-resistant isomers. The other 14C-labelled components in horse urine were unchanged fenclofenac (13....
Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Canadian journal of comparative medicine : Revue canadienne de medecine comparee    April 1, 1983   Volume 47, Issue 2 172-179 
Johnstone IB.Nonsteroidal anti-inflammatory drugs are commonly used in the treatment of inflammatory conditions, and have potential value in the treatment of thrombotic disease in the horse. This study compares the potency of three nonsteroidal anti-inflammatory drugs phenylbutazone, naproxen (equiproxen) and flunixin meglumine (banamine) with respect to their effects on equine platelets. Two functional responses of horse platelets were evaluated in vitro: their ability to aggregate and their ability to make available platelet factor 3 procoagulant activity. Flunixin at a concentration of 10(-6) M signific...
Trimethoprim-sulfadiazine in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration.
American journal of veterinary research    April 1, 1983   Volume 44, Issue 4 540-543 
Brown MP, Kelly RH, Stover SM, Gronwall R.Six healthy adult mares were given a single IV injection of trimethoprim (TMP)-sulfadiazine (SDZ) at a dosage rate of 2.5 mg of TMP/kg of body weight and 12.5 mg of SDZ/kg. Serum, synovial, peritoneal, and urine TMP-SDZ concentrations were measured serially over a 48-hour period. The highest measured mean concentrations of TMP and SDZ were found in the first (0.5 hour) sample of serum, synovial fluid, and peritoneal fluid. The mean peak concentrations of TMP and SDZ averaged 4.37 micrograms/ml and 21.81 micrograms/ml for serum, 2.95 micrograms/ml and 15.31 micrograms/ml for synovial fluid, and...
The pharmacokinetics, plasma protein binding and time response relationships of 2-amino-5-phenyl-2-oxazolin-4-one (pemoline) in the horse.
Drug metabolism and disposition: the biological fate of chemicals    March 1, 1983   Volume 11, Issue 2 120-125 
Igwe OJ, Blake JW.The disposition kinetics of pemoline after iv and oral administration of 2.4 mg/kg of the drug were studied. The elimination half-life was 39.4 hr. The mean volume of distribution was 1.5 liters/kg indicating extensive tissue distribution and sequestration for an amphoteric drug. Plasma protein binding determined by in vitro equilibrium dialysis was concentration dependent. The mean binding capacity was found to be 0.80 mu-mol/g, an apparent dissociation constant of 3.73 X 10(-5) molar, and a total plasma protein concentration of 64.7 g/liter. The mean systemic availability by oral administrat...
Pharmacokinetics of erythromycin in foals and in adult horses.
Journal of veterinary pharmacology and therapeutics    March 1, 1983   Volume 6, Issue 1 67-73 doi: 10.1111/j.1365-2885.1983.tb00456.x
Prescott JF, Hoover DJ, Dohoo IR.The pharmacokinetic parameters of erythromycin in foals were determined following intravenous administration of 5.0 mg/kg to animals aged 1, 3, 5 and 7 weeks. The distribution of the drug was described by a two-compartment open model, and no significant differences were observed between coefficients on which the parameters were based. Pharmacokinetic values were also determined for four mares given 5.0 mg/kg intravenously and for six 10-12-week-old foals given 20.0 mg/kg intravenously. The half-life of erythromycin for all groups of animals (foals less than 7 weeks, mares, foals 10-12 weeks) w...
Gastrointestinal complications associated with the use of atropine in horses.
Journal of the American Veterinary Medical Association    February 1, 1983   Volume 182, Issue 3 229-231 
Ducharme NG, Fubini SL.Atropine sulfate was given at 2 dosages (0.044 mg/kg, 0.176 mg/kg) to clinically normal ponies in order to evaluate the drug's effect on the gastrointestinal tract. Intestinal motility, as assessed by ausculation of borborygmus, was stopped 30 minutes after injection, but it gradually returned to normal within 12 hours. Signs of abdominal pain developed in 3 of 10 ponies. In 3 clinical cases of gastrointestinal disorder, prior atropine treatment was confusing to the diagnostician and resulted in delayed surgical treatment in 1 case. It was concluded that atropine should not be used for allevia...
1 82 83 84 85 86 94